From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics & Gynecology and Women's Health.
Department of Urology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.
Female Pelvic Med Reconstr Surg. 2022 Feb 1;28(2):121-125. doi: 10.1097/SPV.0000000000001085.
The aim of the study was to describe time intervals between pessary maintenance visits in racially diverse women receiving care in a U.S. epicenter of the COVID-19 pandemic. We secondarily aimed to determine whether time interval between pessary changes is associated with adverse outcomes and to identify factors associated with adverse pessary outcomes.
We performed a retrospective study of women undergoing pessary care after the COVID-19 pandemic began. Time between the most recent visit before the pandemic and first visit after the pandemic began was recorded. Pessary care data were collected from the latter visit, including vaginal bleeding, vaginal discharge, and erosion. Patient-reported symptoms and demographics were also recorded. The relationship between time interval between pessary visits and adverse outcomes as well as between adverse outcomes and demographic data was assessed.
We identified 104 women undergoing pessary care, of which 35.6% were Hispanic and 32.7% were Black and 26.2% ± 10.5% lived in poverty. The median time to in-person visit was 4.5 months (interquartile range, 3.7-5.3 months). Seven women (8.7%) had vaginal bleeding, 15 (14.6%) had vaginal discharge, and 7 (6.8%) had erosions. There was no significant association between time interval between pessary visits and adverse outcomes or between adverse outcomes and patient characteristics (all P > 0.05).
Longer duration of time between pessary maintenance visits is not associated with increased adverse outcomes in this group of racially diverse women. Extended intervals between pessary visits can be considered to minimize risk and maintain patient safety during challenging circumstances, such as the COVID-19 pandemic.
本研究旨在描述在美国 COVID-19 大流行中心接受治疗的不同种族女性使用子宫托维持治疗期间的就诊间隔时间。我们的次要目的是确定子宫托更换间隔时间是否与不良结局相关,并确定与不良子宫托结局相关的因素。
我们对 COVID-19 大流行开始后接受子宫托治疗的女性进行了回顾性研究。记录大流行前最近一次就诊与大流行后首次就诊之间的时间间隔。从后者就诊中收集子宫托治疗数据,包括阴道出血、阴道分泌物和糜烂。还记录了患者报告的症状和人口统计学数据。评估了就诊间隔时间与不良结局之间的关系,以及不良结局与人口统计学数据之间的关系。
我们共纳入了 104 名接受子宫托治疗的女性,其中 35.6%为西班牙裔,32.7%为非裔,26.2%±10.5%生活贫困。面对面就诊的中位数时间为 4.5 个月(四分位距,3.7-5.3 个月)。7 名女性(8.7%)有阴道出血,15 名女性(14.6%)有阴道分泌物,7 名女性(6.8%)有糜烂。就诊间隔时间与不良结局之间或不良结局与患者特征之间均无显著相关性(均 P>0.05)。
在这群不同种族的女性中,就诊间隔时间较长与不良结局无关。在 COVID-19 大流行等困难时期,延长子宫托随访间隔时间可以降低风险,保障患者安全。